Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer - Wikidata - wikimedia - TriplyDB

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

http://www.wikidata.org/entity/Q57152489

about

Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines Neoantigen-based cancer immunotherapy Harnessing the immune system to improve cancer therapy Stable long-term cultures of self-renewing B cells and their applications Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity Novel technologies and emerging biomarkers for personalized cancer immunotherapy CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine Trial Watch: Adoptive cell transfer for oncological indications Enhancing Cancer Immunotherapy Via Activation of Innate Immunity Adoptive T-cell therapy for cancer: The era of engineered T cells Evolving immunotherapy strategies in urothelial cancer Acquired and intrinsic resistance in cancer immunotherapy Adoptive T-cell therapy for Leukemia Toxicities of Immunotherapy for the Practitioner To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy Cancer vaccines Immune escape mechanisms as a guide for cancer immunotherapy Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.AACR Cancer Progress Report 2014 High-content molecular profiling of T-cell therapy in oncology Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination Immunotherapy for Gastroesophageal Cancer PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic T-cell receptor gene therapy--ready to go viral?TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity Tumor neoantigens: building a framework for personalized cancer immunotherapy From mice to humans: developments in cancer immunoediting POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer Genetic basis for clinical response to CTLA-4 blockade in melanoma Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.CD4+ T-cell epitope prediction using antigen processing constraints T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.Biopolymer implants enhance the efficacy of adoptive T-cell therapy.T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.

P2860

Q26738680-8FBF8051-247F-4BC5-BDE3-39E7C712D9D1 Q26738693-4377539E-748C-4263-997C-69B8042771CC Q26738698-6FA6901E-116D-4195-A157-68AAEFB31999 Q26766723-3F747B29-8A4D-4FED-8D65-BF2CDAA1F310 Q26769044-0B585FC7-4B48-4C66-AA99-8736F551FEBD Q26769744-6BE27EF8-7A8E-475D-9682-5E2B4DF89A77 Q26770780-2E9F5987-9930-4E92-92A9-62794DAFD197 Q26782520-B6A0DD85-3C6E-4386-914C-455B200ED141 Q26782583-695969DB-CA04-4611-AA5E-77A38EEA58F8 Q26785545-3C5ADCB0-89EE-48EF-84A6-2BCC79B6942D Q26796313-C738F6A0-8623-4848-8C6D-565351A429D2 Q26800611-CBA2C25B-6E2C-402E-9E43-08BD43FB4B96 Q26823557-D0F30F54-CD26-4ECD-B4FF-FE90A7877717 Q26827701-7F91DB9E-9447-4757-BB46-182A48F6827B Q27006934-4866E461-3884-4100-AAD8-A8B1687FCB13 Q27008140-D1F05CF9-FE24-4AE2-86D2-866F50200252 Q27008423-07884C1A-3D97-4379-890B-94B21895744A Q27024438-33C56D65-06AD-4EB4-917C-E8BCAA0B97CF Q27024502-31851CC2-EEAA-456C-B448-03DFF0AED0B1 Q27313856-070B44CD-0105-4E3E-B670-1D3083AC1BA4 Q27346723-A9AE9276-D3AB-4D07-94EC-9C499416D3F1 Q28066792-47969665-8DF5-418F-B2F1-1CAB5A500F1C Q28068378-253C3C8E-2A4D-4ADC-8D9E-43C60E1A7571 Q28069873-3419CF89-3660-459F-A88C-D3E9634A4314 Q28075712-9C229021-C794-4C30-B164-E3904FE9A688 Q28075992-A416FE03-621A-4757-947D-D7788FFEE1AB Q28081611-BF081C53-E271-498A-A953-41B587C58FA6 Q28081699-BC34AF0A-20A9-4800-8173-6160C50A22D3 Q28082704-1E7216C9-AA0E-4A9B-91C3-5D2B16E4E423 Q28088304-36DA4FA6-71D9-41F9-A28A-0400E6B98D33 Q28260529-E44A7D07-29D8-4DCE-8463-AEBDCA7AFBED Q28828457-42854F6E-C1E3-4DEA-B4AD-9FF072940FF3 Q29615679-208DC5EF-3C8A-48C9-BB8D-B78E09DA9C7D Q29620594-B7847727-D3BE-43DB-8371-5B4192DCD313 Q30276874-E3CE9FCB-B7CF-4027-B1E6-21A4FBD171B3 Q30384608-C1F48985-6A68-4DC2-8AD7-BE0BB67074DC Q30491565-E3430B44-CF32-4276-A759-387B9C155466 Q30614247-305AD984-84AE-4D47-9AC0-B29D9F9ED9D0 Q30832820-7475FE1E-D826-4EFD-94B4-722D2491F4B5 Q30846001-81D6BC12-7851-4347-A654-1DA0273187C2

P2860

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

http://www.wikidata.org/entity/Q57152489

description

article publié dans la revue scientifique Science

@fr

im Mai 2014 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Science

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2014

@uk

name

Cancer immunotherapy based on ...... patient with epithelial cancer

@en

Cancer immunotherapy based on ...... patient with epithelial cancer

@nl

type

label

Cancer immunotherapy based on ...... patient with epithelial cancer

@en

Cancer immunotherapy based on ...... patient with epithelial cancer

@nl

prefLabel

Cancer immunotherapy based on ...... patient with epithelial cancer

@en

Cancer immunotherapy based on ...... patient with epithelial cancer

@nl

P1433

Q57152489-3DD38D42-66F4-40E9-B553-0DEF3B5D8566

P1476

Q57152489-D7DB56DC-9B35-4565-88EB-05D839ECACE6

P2093

Q57152489-052AF399-34A5-4033-848A-EDC4EB48A223

Q57152489-27EFF685-470B-45D9-AD9E-6C83399EE7C5

Q57152489-3528C48D-AA93-4BA2-AB07-B304FC299EF6

Q57152489-3B64915F-4FBE-4322-B090-6E131F5F4122

Q57152489-4B18B6B9-0579-4B2E-9339-962319CD885C

Q57152489-4E293934-173E-4FBD-B78F-49341F941A41

Q57152489-A92CBA4D-0397-45B2-9675-24AA3F167350

Q57152489-BA562606-14F2-4D02-BAAD-6D341E711A36

Q57152489-C1BEF2CC-3695-4666-8C2C-D8FD6E5726F1

Q57152489-C462FA0E-2E3D-41C9-A2D7-CD1E9A745895

P2860

Q57152489-2C153997-7543-41B2-9DE3-519F1DD6929D

Q57152489-3A673B4D-A533-43FD-869E-DB7F5D686273

Q57152489-4D8860BF-B525-4F48-8B46-679EE3FB1E9C

Q57152489-5AB8BB8F-AE09-4BB0-BD3F-BF003C765872

Q57152489-5DFDA5F8-BA65-4A6A-95CF-72EB4B19BABB

Q57152489-676D94AF-2074-4908-B241-88D84CF886B9

Q57152489-6E6F85C0-C158-434A-851A-46B65E97F40B

Q57152489-7593A40A-6C2E-4FC6-8A3E-6E9EB7AEC800

Q57152489-7E0E3A89-7F3F-4ED1-B5FA-A4D5223EB123

Q57152489-7E8E8580-4DAB-42FE-90F5-7E09564C6C8A

P304

Q57152489-4F6A2665-0CE5-4F93-AFE1-95440446271B

P31

Q57152489-128D8653-3CA8-4E3C-894E-1CFCF8AD1B75

P356

Q57152489-23EE4B23-541A-414C-8B60-9FB8A995FE70

P407

Q57152489-06D5350E-205D-44B1-816A-88BC0A531F4D

P433

Q57152489-E36CB07A-4B01-48F5-9E3E-2FEA285B85A9

P478

Q57152489-1BDEDAB7-B9ED-4666-AB86-0824F7545A6C

P50

Q57152489-3CE314C2-F915-4729-8DAF-8A175979E7E2

Q57152489-5D4497A1-EC95-47F9-B60A-B970B7418BED

P577

Q57152489-8DB1DF6C-D5AE-4F47-826E-838E49ED8743

P698

Q57152489-6EB79BA1-F36B-4CF3-84BA-467D6DCAA43E

P921

Q57152489-EED00FF1-1501-4426-9351-67BEBB1AA983

Q57152489-F4376040-22A2-494F-8BB9-690F92F6DD70

P932

Q57152489-5EA55647-CB9C-4D7F-A29F-0E578EB2A684

P356

SCIENCE.1251102

P1433

P1476

Cancer immunotherapy based on ...... patient with epithelial cancer

@en

P2093

Christian S Hinrichs

http://www.w3.org/2001/XMLSchema#string

Eric Tran

http://www.w3.org/2001/XMLSchema#string

James C Yang

http://www.w3.org/2001/XMLSchema#string

John R Wunderlich

http://www.w3.org/2001/XMLSchema#string

Katherine Hogan

http://www.w3.org/2001/XMLSchema#string

Maria R Parkhurst

http://www.w3.org/2001/XMLSchema#string

Mark E Dudley

http://www.w3.org/2001/XMLSchema#string

Paul F Robbins

http://www.w3.org/2001/XMLSchema#string

Robert P Somerville

http://www.w3.org/2001/XMLSchema#string

Simon Turcotte

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases.

Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras.

P304

641-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1251102

http://www.w3.org/2001/XMLSchema#string

P407

P433

6184

http://www.w3.org/2001/XMLSchema#string

P478

344

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24812403

http://www.w3.org/2001/XMLSchema#string

P921

P932

6686185

http://www.w3.org/2001/XMLSchema#string